IBM Retirement Fund Sells 749 Shares of Aetna (AET)

IBM Retirement Fund reduced its stake in shares of Aetna (NYSE:AET) by 9.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,033 shares of the company’s stock after selling 749 shares during the period. IBM Retirement Fund’s holdings in Aetna were worth $1,189,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Cetera Advisors LLC raised its holdings in Aetna by 3.3% during the fourth quarter. Cetera Advisors LLC now owns 8,715 shares of the company’s stock valued at $1,573,000 after buying an additional 279 shares in the last quarter. Essex Financial Services Inc. raised its holdings in Aetna by 2.2% during the fourth quarter. Essex Financial Services Inc. now owns 13,787 shares of the company’s stock valued at $2,487,000 after buying an additional 298 shares in the last quarter. Focused Wealth Management Inc raised its holdings in Aetna by 84.5% during the fourth quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock valued at $118,000 after buying an additional 300 shares in the last quarter. Doyle Wealth Management raised its holdings in Aetna by 18.6% during the fourth quarter. Doyle Wealth Management now owns 1,920 shares of the company’s stock valued at $346,000 after buying an additional 301 shares in the last quarter. Finally, RDL Financial Inc. raised its holdings in Aetna by 3.4% during the fourth quarter. RDL Financial Inc. now owns 9,919 shares of the company’s stock valued at $1,789,000 after buying an additional 325 shares in the last quarter. Institutional investors own 84.19% of the company’s stock.

Aetna stock opened at $178.54 on Friday. Aetna has a 52 week low of $142.66 and a 52 week high of $194.40. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $58.40 billion, a PE ratio of 18.11, a price-to-earnings-growth ratio of 1.51 and a beta of 0.64.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.97 by $0.22. Aetna had a return on equity of 21.42% and a net margin of 5.76%. The firm had revenue of $15.34 billion for the quarter, compared to analyst estimates of $15.32 billion. During the same period in the previous year, the company posted $2.71 earnings per share. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. analysts anticipate that Aetna will post 11.06 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 1st. Investors of record on Wednesday, July 25th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, July 24th. This represents a $2.00 annualized dividend and a yield of 1.12%. Aetna’s dividend payout ratio is 20.28%.

A number of equities analysts have recently commented on the company. Credit Suisse Group dropped their price objective on Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a research note on Monday, May 14th. Piper Jaffray Companies reiterated a “buy” rating and issued a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Cantor Fitzgerald upgraded Aetna from a “neutral” rating to an “overweight” rating in a research note on Tuesday, May 1st. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Zacks Investment Research upgraded Aetna from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Eight research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $196.36.

About Aetna

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply